Life sciences distribution is shifting toward AI-powered, resilient networks that improve speed, efficiency, compliance, and ...

Once overlooked as the merely the human body’s plumbing, the lymphatic system is emerging as a new therapeutic frontier, ...

On this weeks episode of the Business of Biotech, Simeon George, M.D., Cofounder and CEO at SR One Capital Management, returns to the show to talk about how SR One evaluates biotech investment targets ...

On this weeks episode of the Business of Biotech, Bret Bostwick, M.D., Venture Partner at Breyer Capital, a family office, talks about his path from medical geneticist to CNS drug development and ...

Autologous CAR-T therapy has transformed cancer treatment, validating the idea that engineered immune cells can produce durable therapeutic responses in patients with otherwise limited options. Yet as ...

A publicly traded life sciences company considering a new director knows how to investigate. It will examine the candidate’s career, reputation, relationships, conflicts, financial interests, and ...

Years ago, a mentor recommended Clayton Christensen’s How Will You Measure Your Life? One story from the book has stayed with me. When Honda entered the U.S. motorcycle market, its deliberate strategy ...

A contract analytical testing and development organization serving pharmaceutical and biotech companies passed its latest FDA inspection with no major findings, a routine General GMP review at its ...

Eastern North Carolina's life sciences sector is expanding rapidly, and workforce development is racing to keep pace. Stephanie Winstead, executive director of Wilson Community College's BEST Center, ...

My father was a lawyer in New York City. He built his own practice from nothing, the way immigrants do. Through discipline, reputation, a little grit, and an almost stubborn insistence on doing right ...

Startups across healthtech/biotech, AI/B2B SAAS and food/agtech sectors competed for investment and connections at a two-day Southeast gathering in Winston-Salem's Innovation Quarter, drawing more ...

On this week's episode of the Business of Biotech, Philina Lee, Ph.D., CEO at AdvanCell, explains how lead-based targeted alpha therapies can unlock deeper, more durable cancer responses, and why ...